Cyclo Therapeutics Inc (NASDAQ:CYTH)

North American company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - CYTH

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - CYTH

  • Market Cap$68.550m
  • IndustryHealthcare
  • SectorDrug Manufacturers - Specialty & Generic
  • Currency
  • ISINUS23254X2018

Company Profile

Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company develops cyclodextrin-based products for the treatment of disease. Its lead drug candidate, Trappsol Cyclo, treats Niemann-Pick Type C disease (NPC). Its other products include Trappsol HPB, Trappsol Fine Chemical, and Aquaplex.CTD Holdings Inc is engaged in marketing and sale of cyclodextrins and related products to food, pharmaceutical and other industries for use in diagnostics and specialty drugs with continuing growth in research and new product development.

Latest CYTH news

Currently there for this company. Visit our news hub for other news .